AusDoc website
  • News
  • Opinion
  • Jobs
    Login Join
    AusDoc website
    AusDoc website
    • Login
    • Create an account
    • About Us
    • Advertise
    • Contact us
    • Privacy
    • Terms and Conditions

    Tag: Obesity

    Semaglutide helps reverse non-alcoholic fatty liver disease, study suggests

    May 7, 2025

    Semaglutide may double the resolution rate of non-alcoholic fatty liver disease in patients with stage 2 or 3 fibrosis, a Novo Nordisk-funded study across 37…

    Call for doctors prescribing semaglutide to refer patients to dietitians

    March 17, 2025

    GPs who prescribe semaglutide should be obliged to also refer those patients on to a dietitian for appropriate counselling, Dietitians Australia says. The organisation’s president…

    ‘They are devastated’: When your patient discovers stopping semaglutide means the weight returns

    March 14, 2025

    Semaglutide is a game changer for patients right up until they stop the treatment, when many face the heartbreak of watching the kilos return. That…

    Hundreds of doctors sent warnings for prescribing semaglutide on PBS to patients without diabetes

    March 11, 2025

    Health officials have started a mass letter mail-out to doctors they suspect are using the PBS to prescribe subsidised semaglutide to patients without diabetes. Without…

    Professor Mark Harris

    TGA approves Wegovy for reducing MACE risk

    February 18, 2025

    The TGA has approved Wegovy to reduce the risk of major adverse events in patients with cardiovascular disease who are overweight or obese. The once-weekly…

    A Mediterranean approach to diet

    January 25, 2025

    The Mediterranean diet is a dietary pattern based on the eating habits and traditional foods from the olive-growing regions of the Mediterranean basin before the…

    Obesity is a disease but not diagnosed with BMI alone, says Lancet Global Commission

    January 15, 2025

    BMI can be used to diagnose obesity but only in conjunction with other measures of body fat, according to a landmark international statement. A Lancet…

    Pharma pushes for GLP-1 receptor agonist to be listed on the PBS for obesity

    January 13, 2025

    Pharmaceutical giant Eli Lilly is readying a PBAC application for tirzepatide, which if successful, would become the first GLP-1 receptor agonist publicly funded for obesity…

    Cryptic pregnancy a reminder to test all women of child-bearing age with symptoms: case study

    December 10, 2024

    A woman with obesity and PCOS who tried unsuccessfully to conceive for years did not realise she was finally pregnant until she was in labour,…

    Telehealth corporate finds its rate of serious clinical errors ‘appears a little high’

    December 2, 2024

    This story has been updated. The findings analysed audited consults including all consultations that an algorithm specifically identified as potential high-risk or critical errors, as…

    Load More

    Login or join to access the full article

    Login or Join

    Latest Articles

    Loading...
    • Home
    • Articles
    • Jobs
    • More

    Loading...

    Telehealth corporate finds its rate of serious clinical errors 'appears a little high'

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Content that breaches the privacy of other individuals
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .